Clinical predictors of Yttrium-90 uptake in hepatocellular carcinoma: towards personalized dosimetry to maximize response to therapy.
10:10 AM – 10:19 AM ET
Accuracy of Scout Dose Y90 Liver Biodistribution For Personalized Treatment Planning of Y90 Radioembolization of HCC: Interim Analysis of a Prospective Clinical Trial
10:20 AM – 10:29 AM ET
Correlation between Tumor Enhancement Measured with Intraprocedural 4D-CT and Tumor Response in Patients with Hepatocellular Carcinoma Treated with Yttrium-90 Radioembolization
10:30 AM – 10:39 AM ET
Safety Profile of Multiple Radiation Segmentectomies in Patients with HCC
10:40 AM – 10:49 AM ET
Experience with Radioembolization for Hepatocellular Carcinoma Complicated by Portal Vein Tumor Thrombus
10:50 AM – 10:59 AM ET
Yttrium-90 Radioembolization in Unresectable Intrahepatic Cholangiocarcinoma: A 17-Year Single-Institution Study
